Physicochemical characterization of diclofenac N-(2-hydroxyethyl)pyrrolidine: Anhydrate and dihydrate crystalline forms

Journal of Pharmaceutical Sciences

Volumn 85, Issue 1, 1996, Pages 16-21

  Ledwidge, Mark T ^a   Draper, Sylvia M ^a   Wilcock, Deborah J ^a   Corrigan, Owen I ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC DERIVATIVE; DICLOFENAC N (2 HYDROXYETHYL)PYRROLIDINE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DEHYDRATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; ENTROPY; HYDRATION; HYDROGEN BOND; INFRARED SPECTROSCOPY; THERMOGRAVIMETRY; TITRIMETRY; X RAY DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHYSICAL; CRYSTALLIZATION; DICLOFENAC; HYDROGEN BONDING; MOLECULAR STRUCTURE; SPECTROPHOTOMETRY, INFRARED; THERMODYNAMICS; WATER; X-RAY DIFFRACTION;

EID: 0030026950     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js950301k     Document Type: Article

References (28)

1. Fini, A.; Fazio, G.; Rapaport, I. Drugs Exp. Clin. Res. 1993, 19, 81-88.
2. Gallacchi, G.; Marcolongo, K. Drugs Exp. Clin. Res. 1993, 19, 95-97.
3. Rosenthal, M.; Bahous, I. Drugs Exp. Clin. Res. 1993, 19, 99-105.
4. Assandri, A.; Canali, S.; Giachetti, C. Drugs Exp. Clin. Res. 1993, 19, 89-95.
5. Jenoure, P.; Segesser, B.; Luhti, U.; Gremion, G. Drugs Exp. Clin. Res. 1993, 19, 125-131.
6. Dreiser, R.; Tisne-Camus, M. Drugs Exp. Clin. Res. 1993, 19, 117-123.
7. Galeazzi, M.; Marcolongo, K. Drugs Exp. Clin. Res. 1993, 19, 107-115.
8. Fini, A.; Fazio, G. Proc. 10th Int. Pharm. Technol. Conf. 1991, 48-64.
9. Eur Patent 271709, 1991.
10. Fini, A.; Fazio, G.; Orienti, I.; Zeechi, V.; Rappaport, I. Pharm. Acta Helv. 1991, 66, 201-203.
11. Fini, A.; Fazio, G.; Rabasco, A.; Holgado Villafuerte, M; Fernandez Hervas, M. J. Proc 13th Int. Pharm. Technol. Conf. 1994, 793-801.
12. Fini, A.; Fazio, G.; Fernandez-Hervas, M. J.; Holgado, M. A.; Rabasco, A. M. Int. J. Pharm. 1995, 121, 19-26.
13. Holgado, M. A.; Fernandez-Hervas, M. J.; Rabasco, A. M.; Fini, A. Int. J. Pharm. 1995, 120, 157-167.
14. Khankari, R.; Grant, D. Thermochim. Acta 1995, 248, 61-79.
15. Giron, D. Thermochim. Acta 1995, 248, 1-59.
16. USP XXII, US Pharmacopoeial Convention Inc.: Rockville, Maryland, 1989, pp 1578-1579.
17. Sheldrick, G. M. Acta Crystallogr. 1990, A46, 467.
18. Sheldrick, G. M. SHELXL93, Program for Crystal Structure Determination, University of Gottingen: Gottingen, Germany 1993.
19. Keller, E. SCHAKAL92, Graphical Representation of Molecular Models, University of Frieburg: Frieburg, Germany 1992.
20. Bryn, S. Solid State Chemistry of Drugs; Academic Press: London, 1982; pp 8-9, 149-188.
21. Ford, J.; Timmins, P. Pharmaceutical Thermal Analysis; Ellis Horwood: Chichester, 1989; p 144.
22. Socrates, G. Infrared Characteristic Group Frequencies, 2nd Ed.; Wiley and Sons: Chichester, 1994; pp 11-17.
23. Shefter, E.; Higuchi, T. J. Pharm. Sci. 1963, 52, 781-791.
24. Dunitz, J. Science 1994, 264, 29.
25. Gilli, A. In Fundamentals of Crystallography; Giacovazzo C., Ed.; Oxford University Press: New York, 1992; pp 465-534.
26. Martinez, H.; Bryn, S. R.; Pfeiffer, R. P. Pharm Res. 1990, 7, 147-153.
27. Craven, B. Nature 1976, 260, 727-729.
28. Forbes, R. T.; York, P.; Fawcett, V.; Shields, L. Pharm. Res. 1992, 9, 1428-1435.